Rule 3342-10-02.3 | Administrative policy regarding institutional biosafety committee.
(A) Purpose. Institutions that receive support from the national institutes of health (NIH) for recombinant or synthetic nucleic research are required to establish and register an institutional biosafety committee (IBC) with the NIH office of biotechnology activities in compliance with the NIH guidelines.
(B) The vice president for research and sponsored programs is responsible for establishing an IBC, including appointment of IBC members, in accordance with NIH guidelines.
(C) The IBC activities, scope of review and operating procedures shall be governed by a charter developed by the IBC in accordance with NIH guidelines and approved by the vice president for research and sponsored programs.
Supplemental Information